GSTO1-1 upregulation has been reported in various cancers, including pancreatic cancer [52], esophageal adenocarcinoma [53,54], colorectal cancer [55], and ovarian cancer, where the upregulation has been associated with drug resistance [24,56]. The gene discussed is GSTO1; the disease is cancer.